These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3040212)
1. Tumor-associated antigens in breast carcinomas. Prognostic significance. Cohen C; Sharkey FE; Shulman G; Uthman EO; Budgeon LR Cancer; 1987 Sep; 60(6):1294-8. PubMed ID: 3040212 [TBL] [Abstract][Full Text] [Related]
2. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267 [TBL] [Abstract][Full Text] [Related]
3. Prognosis in stage II (T1N1M0) breast cancer. Rosen PP; Saigo PE; Braun DW; Weathers E; Kinne DW Ann Surg; 1981 Nov; 194(5):576-84. PubMed ID: 6271083 [TBL] [Abstract][Full Text] [Related]
4. Treatment and survival of female patients with nonpalpable breast carcinoma. Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064 [TBL] [Abstract][Full Text] [Related]
5. Tissue carcinoembryonic antigen in the prognosis of early invasive breast cancer. Hegg R; De Souza AZ; Pestana CB; Cardoso de Almeida PC Breast Cancer Res Treat; 1990 May; 15(3):213-6. PubMed ID: 2164851 [TBL] [Abstract][Full Text] [Related]
6. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Fisher ER; Swamidoss S; Lee CH; Rockette H; Redmond C; Fisher B Cancer; 1978 Oct; 42(4):2025-31. PubMed ID: 213191 [TBL] [Abstract][Full Text] [Related]
7. Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast. Carter D; Pipkin RD; Shepard RH; Elkins RC; Abbey H Am J Surg Pathol; 1978 Mar; 2(1):39-46. PubMed ID: 205137 [TBL] [Abstract][Full Text] [Related]
8. The distance between breast cancer and the skin is associated with axillary nodal metastasis. Eom YH; Kim EJ; Chae BJ; Song BJ; Jung SS J Surg Oncol; 2015 Jun; 111(7):824-8. PubMed ID: 25847102 [TBL] [Abstract][Full Text] [Related]
9. The clinical value of tissue carcinoembryonic antigen in breast cancer. Haga S; Watanabe O; Shimizu T; Imamura H; Iida T; Makita M; Kajiwara T Jpn J Surg; 1991 May; 21(3):278-83. PubMed ID: 1649933 [TBL] [Abstract][Full Text] [Related]
10. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203 [TBL] [Abstract][Full Text] [Related]
11. Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer. Gion M; Mione R; Gatti C; Dittadi R; Leon A; Castiglioni C; Nascimben O; Bruscagnin G Breast Cancer Res Treat; 1990 Nov; 17(1):15-21. PubMed ID: 1965704 [TBL] [Abstract][Full Text] [Related]
12. Paget's disease of the breast: the influence of the presence or absence of an underlying palpable tumor on the prognosis and on the choice of treatment. Rissanen PM; Holsti P Oncology; 1969; 23(3):209-16. PubMed ID: 4306622 [No Abstract] [Full Text] [Related]
13. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases. Elson CE; Kufe D; Johnston WW Anal Quant Cytol Histol; 1993 Jun; 15(3):171-8. PubMed ID: 7688511 [TBL] [Abstract][Full Text] [Related]
15. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases. Verbanac KM; Min CJ; Mannie AE; Lu J; O'Brien KF; Rosman M; Tafra L; Ann Surg Oncol; 2010 Oct; 17 Suppl 3():368-77. PubMed ID: 20853060 [TBL] [Abstract][Full Text] [Related]
17. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455 [TBL] [Abstract][Full Text] [Related]
18. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229 [TBL] [Abstract][Full Text] [Related]
19. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer]. Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461 [TBL] [Abstract][Full Text] [Related]
20. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]